All stock lists
Red Rock Resorts, Inc. (NASDAQ:RRR)
US · Delayed Price · Currency is USD
Consumer Cyclical · Gambling, Resorts & Casinos
50.44+0.83 (+1.66%)
Insider Score
––Not scored
RRR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RRR analyst forecast
RRR analyst consensus
Moderate Buy7 ratings
Buy 6 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
RRR 12-month price target
$65.00+28.6% upsideaverage of 1 firm
$65.00High
$65.00Low
Best analysts covering RRR
- Jefferies100%success rate · 1 call
- Wells Fargo78%success rate · 9 calls
- Mizuho75%success rate · 4 calls
- Susquehanna71%success rate · 7 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
RRR analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-10-20 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-10-19 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-10-19 |
| Goldman Sachs | — | $65.00 | +29.5% | — | 2026-10-13 | |
| — | Citigroup | Buy | — | — | Reiterated | 2026-10-12 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-09 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-10-07 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-08-17 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-08-05 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-08-05 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-08-05 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-08-05 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-07-21 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-20 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-07-20 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-07-15 |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2026-07-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-07-09 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2026-06-26 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-05-19 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-01 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-04-30 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-04-30 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-30 |
| — | Susquehanna | Positive | — | — | Reiterated | 2026-04-30 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-04-30 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-04-30 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-04-30 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-04-21 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-16 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-04-08 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-04-06 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-02-12 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-02-12 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-02-11 |
| — | Susquehanna | Positive | — | — | Reiterated | 2026-02-11 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-02-11 |
| — | Stifel | Buy | — | — | Reiterated | 2026-02-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-16 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-01-14 |
| — | Jefferies | Buy | — | — | Reiterated | 2025-12-24 |
| — | Jefferies | Buy | — | — | Upgraded | 2025-11-04 |
| — | Macquarie | Outperform | — | — | Reiterated | 2025-10-29 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-10-29 |
| — | Stifel | Hold | — | — | Reiterated | 2025-10-29 |
| — | Susquehanna | Positive | — | — | Reiterated | 2025-10-29 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-10-21 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-09-16 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-08-06 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-07-31 |
| — | Stifel | Hold | — | — | Reiterated | 2025-07-30 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-07-30 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-07-30 |
| — | Susquehanna | Positive | — | — | Reiterated | 2025-07-30 |
| — | Susquehanna | Positive | — | — | Reiterated | 2025-07-24 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-07-18 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-07-18 |
| — | Truist Securities | Buy | — | — | Upgraded | 2025-07-16 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-07-11 |
| — | Mizuho | Outperform | — | — | Upgraded | 2025-06-02 |
RRR earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-10 | 0.41 | 0.75 | $503.5M | $511.8M |
| 2026-04-29 | 0.54 | 0.73 | $505.6M | $507.3M |
| 2026-08-04 | 0.51 | 0.67 | $500.1M | $510.3M |
| 2026-11-03 | 0.45 | 0.00 | $478.1M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.